Cillian King

Fundador en

Koala Life Sciences BV

Finance

Health Technology

Consumer Services

Perfil

Dr. Cillian King is a Partner at EQT Life Sciences Group BV and a Founder at Koala Life Sciences BV.
He is on the Board of Directors at Sairopa B V, Muna Therapeutics ApS and QurAlis Corp.
Dr. King was previously employed as a Chairman-Supervisory Board by Allero Therapeutics BV and an Investment Manager by Swanbridge Capital Management BV.
He received his doctorate degree from Vrije Universiteit Amsterdam.

Cargos activos de Cillian King

Empresas	Cargo	Inicio
Muna Therapeutics ApS Muna Therapeutics ApS BiotechnologyHealth Technology Engages in discovering and developing of therapies that slow and stop devastating neurodegenerative, alzheimer’s & parkinson’s diseases	Director/Miembro de la Junta	-
LSP Management Group BV LSP Management Group BV Investment ManagersFinance EQT Life Sciences invests in companies located across the globe. The firm targets companies operating in the fields of therapeutics, medical devices, diagnostics and healthtech sectors. It provides financing for early and later stage capital requirements with an investment size of EUR 10 – 60 million.	Inversor de Capital Privado	01/01/2021
Koala Life Sciences BV	Fundador	01/01/2017
QurAlis Corp. QurAlis Corp. Pharmaceuticals: MajorHealth Technology Develops precision medications	Director/Miembro de la Junta	-
Sairopa B V Sairopa B V MiscellaneousMiscellaneous Develops medicines and functions as an investment holding company	Director/Miembro de la Junta	01/01/2021

Todos los cargos activos de Cillian King

Antiguos cargos conocidos de Cillian King.

Empresas	Cargo	Fin
Swanbridge Capital Management BV Swanbridge Capital Management BV Investment ManagersFinance Swanbridge Capital invests in Life Sciences companies located in the Rotterdam Science Tower we are in the very heart of the Life Sciences startup eco-system. The firm invests in early stage companies.	Inversor de Capital Privado	01/01/2021
Allero Therapeutics BV Allero Therapeutics BV Miscellaneous Commercial ServicesCommercial Services Develops immunotherapy treatment for allergic and autoimmune diseases	Presidente	01/01/2021

Ver el detalle de la experiencia de Cillian King.

Formación de Cillian King.

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Ver el detalle de la experiencia de Cillian King.

Relaciones

Relaciones de 1er grado

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Consultar la red personal

Empresas relacionadas

Empresas privadas	8
LSP Management Group BV LSP Management Group BV Investment ManagersFinance EQT Life Sciences invests in companies located across the globe. The firm targets companies operating in the fields of therapeutics, medical devices, diagnostics and healthtech sectors. It provides financing for early and later stage capital requirements with an investment size of EUR 10 – 60 million.	Finance
Vrije Universiteit Amsterdam Vrije Universiteit Amsterdam Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Swanbridge Capital Management BV Swanbridge Capital Management BV Investment ManagersFinance Swanbridge Capital invests in Life Sciences companies located in the Rotterdam Science Tower we are in the very heart of the Life Sciences startup eco-system. The firm invests in early stage companies.	Finance
QurAlis Corp. QurAlis Corp. Pharmaceuticals: MajorHealth Technology Develops precision medications	Health Technology
Allero Therapeutics BV Allero Therapeutics BV Miscellaneous Commercial ServicesCommercial Services Develops immunotherapy treatment for allergic and autoimmune diseases	Commercial Services
Muna Therapeutics ApS Muna Therapeutics ApS BiotechnologyHealth Technology Engages in discovering and developing of therapies that slow and stop devastating neurodegenerative, alzheimer’s & parkinson’s diseases	Health Technology
Koala Life Sciences BV
Sairopa B V Sairopa B V MiscellaneousMiscellaneous Develops medicines and functions as an investment holding company	Miscellaneous